COVID-19 frequently asked inpatient questions: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
Aisha Adigun (talk | contribs) No edit summary |
||
| Line 5: | Line 5: | ||
{{CMG}}{{AE}}{{GDS}}{{Aisha}}{{HAR}}{{RAB}}{{Nuha}}{{IF}}}{{SaraH}} | {{CMG}}{{AE}}{{GDS}}{{Aisha}}{{HAR}}{{RAB}}{{Nuha}}{{IF}}}{{SaraH}} | ||
{{SK}} Novel coronavirus, covid-19, COVID-19, SARS-CoV-2, Wuhan coronavirus | {{SK}} Novel coronavirus, covid-19, COVID-19, SARS-CoV-2, Wuhan coronavirus, severe acute respiratory syndrome coronavirus 2, 2019-nCoV, COVID, coronavirus disease, novel coronavirus | ||
'''Sources of content-''' [https://www.cdc.gov/coronavirus/2019-ncov/index.html CDC], [https://www.who.int/emergencies/diseases/novel-coronavirus-2019 WHO], and [https://www.fda.gov/emergency-preparedness-and-response/counterterrorism-and-emerging-threats/coronavirus-disease-2019-covid-19 FDA]. | '''Sources of content-''' [https://www.cdc.gov/coronavirus/2019-ncov/index.html CDC], [https://www.who.int/emergencies/diseases/novel-coronavirus-2019 WHO], and [https://www.fda.gov/emergency-preparedness-and-response/counterterrorism-and-emerging-threats/coronavirus-disease-2019-covid-19 FDA]. | ||
Revision as of 15:29, 1 July 2020
|
Frequently Asked Inpatient Questions Microchapter |
To visit COVID-19 Project page, click here
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Gurmandeep Singh Sandhu,M.B.B.S.[2] Aisha Adigun, B.Sc., M.D.[3]Harmeet Kharoud M.D.[4]Rinky Agnes Botleroo, M.B.B.S.Nuha Al-Howthi, MD[5]Ifrah Fatima, M.B.B.S[6]}Sara Haddadi, M.D.[7]
Synonyms and keywords: Novel coronavirus, covid-19, COVID-19, SARS-CoV-2, Wuhan coronavirus, severe acute respiratory syndrome coronavirus 2, 2019-nCoV, COVID, coronavirus disease, novel coronavirus
Sources of content- CDC, WHO, and FDA.